On Friday, the Food and Drug Administration approved the antibody drug omalizumab as an injection to lessen allergic reactions to foods in people ages 1 and up. “While it will not eliminate food allergies or allow patients to consume food allergens freely, its repeated use will help reduce the health impact if accidental exposure occurs.” The FDA notes that 17 percent of the people who received the drug had no significant improvement in their sensitivity to allergy-triggering food.

Source: New FDA-approved drug makes severe food allergies less life-threatening